A luxury care home for people with dementia – but at what price?
Chelsea Court Place describes itself as the UK’s first luxury purpose-built and designed residential and daycare home for people with Alzheimer’s and dementia. Inside the building on the exclusive King’s Road in London, it feels more like a private members’ club or a five-star hotel than a care home, with its thick carpets, tasteful paintings and wall hangings.
There are none of the familiar smells of toilets, disinfectant or overcooked food that often rudely greet visitors to such establishments. Here, there is a private cinema, luxury spa and treatment rooms, and a library stocked with sumptuous coffee-table volumes. Its 15 elegantly furnished en suite “apartments” are set in a horseshoe shape around the central dining area, where a restaurant and 24-hour cafe for residents and visitors offer tailored food choices to suit individual nutritional needs.
Chelsea Court, which opened last month, also offers bridge evenings and outings to opera, tennis, golf and local attractions. The nursing team are all dementia specialists assisted by the latest technology. Each resident is tracked by “person-centred software”, which monitors progress through the day and offers staff an insight into why and when extra care or attention should be given if patients become agitated or confused. Dementia care mapping, an innovative observational technique, takes a complete history of each resident, offering insights into situations that can lead to mood changes.
Mwaya Siwale, the head of memory care, gives an example of a resident who gets “fidgety and anxious around 5pm”. “Relatives told us this was the time when she used to lock her shop. So at around five we have created a plan to reduce that anxiety. We also learned she is really attached to a particular carpet and does not like light-coloured curtains – so that carpet will be in her room and she will have dark curtains.”
Chelsea Court is the brainchild of hotelier and philanthropist Laurence Geller. His experience of seeing the impact of dementia on a relative drove his interest in improving care and treatment. Geller is co-chair of the Alzheimer’s Society appeal board, which aims to raise £100m a year for dementia research, and chancellor of the University of West London. Chelsea Court aims to champion research and innovation in partnership with the university, which is “spearheading new attitudes to dementia care, tailored medication and investing in research to help find a cure for dementia”.
Last week the Office for National Statistics announced that dementia has replaced heart disease as the leading cause of death in England and Wales. There are thought to be 850,000 people with dementia in the UK at an estimated cost to the economy of £26bn a year. With better diagnosis and rising life expectancy rates, numbers are set to reach two million by 2051, when one in three people over the age of 65 will have the disease and costs may treble.
Hiç yorum yok:
Yorum Gönder